Gyre Therapeutics, Inc. GYRE
4.56 USD +0.55 (+13.72%)
Nov 6, 2026, 12:02 PM EST
4.08 Day range 4.66
3.97 52-week range 9.14
- YTD
- -35.41%
- 1 year
- -37.87%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 116.59M | 105.76M | 113.45M | 102.29M | 7.34M | |
| 111.17M | 101.87M | 108.81M | 97.50M | -42.00K | |
| 11.49M | 16.16M | -67.23M | 9.20M | -87.89M | |
| 5.03M | 12.09M | -92.93M | 2.30M | -87.93M | |
| 0.02 | 0.05 | -1.41 | 0.03 | -43.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 49.19M | 11.81M | 33.51M | 25.18M | 44.35M | |
| 219.76M | 125.41M | 116.54M | 84.75M | 55.66M | |
| 31.40M | 27.00M | 38.06M | 12.54M | 14.57M | |
| 3.42M | 1.60M | 409.00K | 613.00K | 2.38M | |
| 62.50M | 63.32M | -15.83M | 42.52M | 41.09M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.01M | -3.64M | 25.89M | 10.68M | -83.75M | |
| -474.00K | -19.88M | -19.76M | -13.81M | 48.19M | |
| 24.38M | 2.10M | 2.50M | 0 | 49.55M | |
| -1.16M | -1.91M | -7.85M | -4.99M | -839.00K | |
| 25.26M | -21.70M | 8.33M | -5.03M | 13.99M |